Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (371-380 of 776) with videos related to

Pageof 78
Sort By:
Scientific Reports|July 7, 2016
Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's diseaseJulia Muenchhoff, Anne Poljak, Anbupalam Thalamuthu, et al.
Neuropsychologia|May 3, 2011
Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL studyKerryn E Pike, Kathryn A Ellis, Victor L Villemagne, et al.
Journal of Molecular Biology|January 27, 2006
Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor proteinMatthias Gralle, Cristiano L P Oliveira, Luiz H Guerreiro, et al.
Plos One|October 3, 2015
Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-MonthsChristine Thai, Yen Ying Lim, Victor L Villemagne, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Neurobiology of Aging|January 21, 2025
The moderating effect of diet on the relationship between depressive symptoms and Alzheimer's disease-related blood-based biomarkersHilal Salim Said Al Shamsi, Samantha L Gardener, Stephanie R Rainey-Smith, et al.
Age and Ageing|January 22, 2026
Prevalence of frailty and its association with cognition in preclinical Alzheimer's disease: a cross-sectional analysis of baseline data from the A4 studyAndrew L H Huynh, Shunran Wang, Kathryn Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Pageof 78

Showing results (371-380 of 776) with videos related to

Sort By:
Pageof 78
Scientific Reports|July 7, 2016
Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's diseaseJulia Muenchhoff, Anne Poljak, Anbupalam Thalamuthu, et al.
Neuropsychologia|May 3, 2011
Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL studyKerryn E Pike, Kathryn A Ellis, Victor L Villemagne, et al.
Journal of Molecular Biology|January 27, 2006
Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor proteinMatthias Gralle, Cristiano L P Oliveira, Luiz H Guerreiro, et al.
Plos One|October 3, 2015
Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-MonthsChristine Thai, Yen Ying Lim, Victor L Villemagne, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Neurobiology of Aging|January 21, 2025
The moderating effect of diet on the relationship between depressive symptoms and Alzheimer's disease-related blood-based biomarkersHilal Salim Said Al Shamsi, Samantha L Gardener, Stephanie R Rainey-Smith, et al.
Age and Ageing|January 22, 2026
Prevalence of frailty and its association with cognition in preclinical Alzheimer's disease: a cross-sectional analysis of baseline data from the A4 studyAndrew L H Huynh, Shunran Wang, Kathryn Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Pageof 78